Related Party Transactions |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 14. Related Party Transactions On April 30, 2026, the Company entered into a letter agreement with Bios Partners, L.P., on behalf of certain Bios entities holding securities of the Company. Pursuant to the letter agreement, the Bios entities agreed to defer the conversion of 12,232 shares of the Company’s Series X Non-Voting Convertible Preferred Stock held by the Bios entities and waived the Company’s obligation under the Certificate of Designation of Series X Non-Voting Convertible Preferred Stock to reserve the shares of common stock issuable upon conversion of such preferred shares until the Company has amended its Restated Certificate of Incorporation to increase its authorized common stock. In addition, subject to certain exceptions, the Bios entities agreed not to sell, transfer or otherwise dispose of, directly or indirectly, any Series X Non-Voting Convertible Preferred Stock or the underlying shares of common stock for a period ending April 30, 2029. In consideration for the agreements and waivers of the Bios entities, the Company issued warrants to the Bios entities to purchase an aggregate of 3,000,000 shares of the Company’s common stock at an exercise price of $1.00 per share (the “Bios Warrants”). The Bios Warrants are exercisable beginning October 27, 2026, and expire on April 30, 2031. The Bios Warrants are subject to a 180-day lock-up period pursuant to FINRA Rule 5110(e). |